Axolotl Announces Reseller Agreement With Sunquest; Web-based Lab Results Delivery and Ordering From Sunquest.

MOUNTAIN VIEW, Calif.--(BW HealthWire)--Dec. 16, 1999--

Axolotl Corp., the leader in Clinical Messaging software, and Sunquest Information Systems, Inc. (NASDAQ-SUNQ), a market leader in clinical data management with over 1,200 sites worldwide, announced today the signing of a Value Added Reseller (VAR) agreement. Under the agreement, Sunquest will remarket, co-label, implement and support Axolotl's web-based Elysium Access and Elysium Intelligent Ordering products together with Sunquest's industry-leading FlexiLab(R) laboratory information system (LIS).

A member of Axolotl's Elysium product suite, Elysium Access harnesses the Internet, e-mail, and powerful automation tools to link physicians, clinics, labs, and hospitals. Elysium Intelligent Ordering provides comprehensive web-based ordering of lab tests with "interactive" forms that incorporate medical necessity rules, automatic Advanced Beneficiary Notice (ABN) generation, labeling and alerts. Physicians and their staffs use standard Web browsers to access lab results and manage the order entry process with their lab providers.

Commenting on the alliance, Sunquest's Chief Executive Officer, Dr. Sidney Goldblatt said, "We selected Axolotl following a comprehensive survey of the web-based clinical information products available in the marketplace. With the Elysium Access and Elysium Intelligent Order products, Sunquest will enable its many FlexiLab customers to leverage the web to gain competitive advantage and lower operating costs as they grow their outreach programs."

"Like Axolotl, Sunquest has a market reputation for high quality products and service" stated Ray Scott, President of Axolotl. "We are pleased to have the opportunity to enable a leading provider of Laboratory Information Systems to deliver more value to their customers."

The marketing and sales programs related to this announcement are already underway and market feedback from both Axolotl and Sunquest has confirmed the readiness of hospitals and IDNs to embrace the use of Internet technologies to enhance the services they deliver to their respective communities.

About Sunquest Information Systems, Inc.

Sunquest Information Systems Inc. designs, develops and supports a comprehensive suite of information products for hospitals and healthcare networks - to include laboratory, radiology and pharmacy information systems. Characterized by superior service, Tucson-based Sunquest also develops Clinical Event Manager, a cross-platform communication system that issues clinical alerts via e-mail or pager. Sunquest's consulting division, Balanced View Consulting, provides a wide array of management and technical tools including lab redesign and optimization, outreach and lab network program development, and operational, business and implementation plans. Founded in 1979, Sunquest is a market leader in clinical data management with over 1,200 sites worldwide. Visit www.sunquest.com.

About Axolotl

Axolotl recently merged with AccentHealth, Inc. The combined company is a leader in the rapidly expanding e-health market reaching more than 20 million medical waiting room visitors each month, 52,000 physicians and the general public. AccentHealth's acclaimed consumer Web-site (www.accenthealth.com), broadband satellite ISP capabilities and award-winning Waiting Room Television Network, has established a large and growing base of loyal physicians and patients. Axolotl's Web-based clinical messaging products, known as Elysium, provide secure clinical communication between physicians, hospitals, laboratories, pharmacies, radiology centers and medical groups and are in use throughout the U.S.

For more information, contact Steve Sedlock, Vice President of Marketing and Sales, Axolotl, 800 El Camino Real West, Suite 150, Mountain View, California, 94040. Phone: [phone];E-mail: [e-mail]. Visit the Axolotl Web site www.axolotl.com for more information about the Elysium product suite.

Statements in this press release concerning the Company's business outlook or future economic performance, anticipated profitability, revenues, expenses or other financial items, and service offering growth, together with other statements that are not historical facts, are "forward-looking statements" as that term is defined under the Federal Securities Laws. Any forward-looking statements are estimates, reflecting the best judgment of the party making such statements based upon currently available information and involve a number of risks, uncertainties and other factors which could cause actual results to differ materially from those stated in such statements.